Open AccessPrimary Langerhans Cell Histiocytosis in Thyroid
Author(s) -
Ayberk Dursun,
Emel Ebru Pala,
Levent Uğurlu,
Cengiz Aydın
Publication year - 2020
Publication title -
acta endocrinologica (bucharest)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.249
H-Index - 13
eISSN - 1843-066X
pISSN - 1841-0987
DOI - 10.4183/aeb.2020.501
Subject(s) - medicine , thyroid , langerhans cell histiocytosis , pathological , histiocytosis , goiter , chemotherapy , pathology , rare disease , disease , surgery , dermatology
Langerhans cell histiocytosis (LCH) is a rare group of neoplastic diseases resulting from Langerhans dendritic cells. The most common site (80%) is bones. Thyroid gland involvement is exceedingly rare and usually expected to be seen as a part of multisystemic disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom